Abstract
We report on two patients who developed a secondary acute myeloid leukemia (sAL) after treatment for non-Hodgkin's lymphoma (NHL) with regimens containing low to intermediate doses of VP16. Clinical and hematologic features in these two patients were consistent with epipodophyllotoxin- associated sAL. In one case, a rearrangement of chromosome band 11q23 was detected.
| Original language | English |
|---|---|
| Pages (from-to) | 758-759 |
| Number of pages | 2 |
| Journal | Haematologica |
| Volume | 83 |
| Issue number | 8 |
| Publication status | Published - 1998 |
Keywords
- Secondary leukemia
- VP16
ASJC Scopus subject areas
- Hematology
Fingerprint Dive into the research topics of 'Secondary acute myeloid leukemia following treatment with VP16- containing regimens for non-Hodgkin's lymphoma'. Together they form a unique fingerprint.
Cite this
Orlandi, E., Lazzarino, M., Bernasconi, P., Astori, C., & Bernasconi, C. (1998). Secondary acute myeloid leukemia following treatment with VP16- containing regimens for non-Hodgkin's lymphoma. Haematologica, 83(8), 758-759.